La jolla Pharmaceutical

La Jolla Pharmaceutical Company |.

Launch date

1989

Employees

Market cap

Enterprise valuation

AUD240m (Public information from Aug 2022)

San Diego California (HQ)

https://www.lajollapharmaceutical.com/

https://twitter.com/lajollapharma https://www.linkedin.com/company/la-jolla-pharmaceutical-company

Revenues, earnings & profits over time

USD	2016	2017	2018	2019	2020	2021	2022
Revenues	-	-	10.0m	23.0m	33.0m	76.0m	56.0m
% growth	-	-	-	130 %	43 %	130 %	(26 %)
EBITDA	-	(114m)	-	-	-	-	-
Profit	-	(115m)	(199m)	(117m)	(39.0m)	15.0m	-
% profit margin	-	-	(1990 %)	(509 %)	(118 %)	20 %	-
EV / revenue	-	-	7.4x	4.7x	3.2x	1.5x	2.0x
EV / EBITDA	-	-5.5x	-	-	-	-	-
R&D budget	64.9m	78.1m	112m	79.2m	-	-	-
R&D % of revenue	-	-	1122 %	344 %	-	-	-

Source: Dealroom estimates

Date	Investors	Amount	Round
Dec 2005	N/A	N/A	IPO
Apr 2011	N/A	$5.2m	Early VC
Oct 2013	N/A	$17.8m	Post IPO Equity
Aug 2022*	Innoviva	N/A	Acquisition
Total Funding		AUD8.0m

Tetraphase Pharmaceuticals

ACQUISITION by La jolla Pharmaceutical Jul 2020